Stay updated on Milademetan Safety in AML/MDS Clinical Trial

Sign up to get notified when there's something new on the Milademetan Safety in AML/MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Milademetan Safety in AML/MDS Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page shows a new revision label: v3.3.2 replacing v3.3.1, a minor technical update that does not affect the study information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T16:40:17.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now displays an updated revision banner: Revision v3.3.1 replaces Revision v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T12:42:47.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Removed the general government funding update notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T06:22:02.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    There are no substantive changes to the study content; only minor cosmetic and layout adjustments are visible across sections. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T00:57:47.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Core clinical content (the disease name) was removed; a new version tag (v3.2.0) and an operational status notice were added, signaling a page update and potential deprecation of the previous content.
    Difference
    2%
    Check dated 2025-10-05T08:24:11.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.
    Difference
    0.1%
    Check dated 2025-09-28T03:00:49.000Z thumbnail image

Stay in the know with updates to Milademetan Safety in AML/MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Milademetan Safety in AML/MDS Clinical Trial page.